Back to search

Democritus University of Thrace (DUTH)

Μελέτη των προϊόντων σύνθεσης και αποδόμησης του κολλαγόνου τύπου-Ι στη χρόνια καρδιακή ανεπάρκεια

Abstract

dc:description

Heart failure is a highly complex clinical syndrome that involves structural, hormonal and molecular changes. Volume overload, pressure overload or myocardial injury produces a sustained abnormal elevation in myocardial wall stress which initiates cardiac remodelling that frequently results in ventricular decompensation and heart failure. In heart failure, turnover of the extracellular matrix (ECM) is the main factor determining cardiac remodelling. The fibrillar interstitial types I and III collagens are the major structural components of the cardiac ECM. Approximately 85% of the total collagen in the heart consists of type I collagen. The assessment of collagen- derived serum peptides, amino- terminal propetide of procollagen type I (PINP) and the carboxy- terminal telopeptide of collagen type I (CITP), has been proposed as a useful tool to address myocardial fibrosis from a distance. Aim of the present study was the investigation of the prognostic value of the levels of collagen- derived serum peptides, PINP and CITP, in CHF patients of different underlying aetiology during a 12 months follow- up. Furthermore, we investigated the association between the levels of collagen serum derived peptides and quality of life in CHF patients. We studied 196 consecutive patients (126 male, 70 female, mean age 69± 10 years), who were admitted to our Cardiology Department’s Care Unit of Democritus University with acute decompensation of the syndrome. The study entry point was determined at the discharge of the patients, where they were characterized by a stable CHF status. At this point, a blood collection from a peripheral vein and clinical examination were performed. The primary endpoint of the study was cardiac mortality during a 12 months follow- up. The secondary endpoint was the rehospitalization for decompensation of CHF during a 12 months follow- up. Finally, we assessed a surrogate endpoint, which was the association between the serum levels of collagen derived peptides and the quality of life. The prognostic value of the variables of the study was assessed by univariate and multivariate Cox proportional hazard analyses models. Also, Kaplan- Meier survival plots were calculated from baseline to the final follow- up. Spearman correlation analysis was used for the determination of the surrogate endpoint. The quality of life was determined by the MLHFQ score (Minnesota Living with Heart Failure Questionnaire). We assessed the serum levels of CITP and PINP by commercially available immunoassays (ELECSYS 1010, Roche Diagnostics Ltd, Switzerland). The results regarding the primary endpoint were a) the high vs. low serum levels of CITP represent an independent prognostic marker of cardiac mortality during a 12 months follow- up, b) the CITP serum levels have an additive prognostic value on the NT-proBNP serum levels, and c) the high vs. low levels of PINP were not prognostic of cardiac death during a 12 months follow- up. Furthermore, the results regarding the secondary endpoint were a) the high vs. low levels of CITP could not predict rehospitalizations during a 12 months follow- up, b) the high vs. low levels of PINP showed a tendency to predict rehospitalizations during a 12 months follow- up, and c) the high vs. low levels of NT-proBNP were independent prognostic marker of rehospitalizations during a 12 months follow- up. In addition, the results regarding the surrogate endpoint were a) the discharge serum levels of CITP and PINP were significantly correlated with MLHFQ score at 6 months follow- up, but not with the MLHFQ score at 12 months follow- up, and b) the serum levels of CITP at 6 and 12 months were significantly correlated with the MLHFQ score at the same time, but such a correlation was not observed for the serum levels of PINP. In conclusion, the serum levels of CITP are an independent prognostic biomarker of cardiac mortality, with additive prognostic value on serum levels of NT-proBNP, in CHF patients during a 12 months follow- up. The collagen derived serum peptides, also, are correlated with quality of life in CHF patients. These findings suggest the determinant role of myocardial fibrosis in the evolution of heart failure and propose novel markers for risk stratification in CHF syndrome.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Χατζηκυριάκου, Σοφία
  • Chatzikyriakou, Sofia

Subjects

dc:subject × 19

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/26015

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Χατζηκυριάκου, Σοφία; Chatzikyriakou, Sofia. Μελέτη των προϊόντων σύνθεσης και αποδόμησης του κολλαγόνου τύπου-Ι στη χρόνια καρδιακή ανεπάρκεια. Democritus University of Thrace (DUTH), 2009. http://hdl.handle.net/10442/hedi/26015